FindTrial
Sign In

Effect of Comprehensive Myopia Controlling Measures on the development of myopia

Effect of Comprehensive Myopia Controlling Measures on the development of myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOC-17013873
Enrollment
Unknown
Registered
2017-12-13
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

case grooup:comprehensive controlling measures
control group:follow-up

Sponsors

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 8 Years

Inclusion criteria

Inclusion criteria: 1. Children in first year of primary school; 2. No strabismus, amblyopia or other ocular diseases; 3. No systemic diseases which may affect the visual development process.

Exclusion criteria

Exclusion criteria: (1) Unable to cooperate in ocular examination; (2) Having contraindications against atropin; (3) Having applied atopine or pirenzepine; (4) Allergic to atropin, cyclopentanone, proparacaine or benzalkonium chloride; (5) Unable to wearing the orthokeratology; (6) Unwilling to participate in this study; (7) Unable to complete the 2-year follow-up.

Design outcomes

Primary

MeasureTime frame
incidence of myopia;change of refraction;change of axial length;—

Countries

China

Contacts

Public ContactWang Ningli

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University

wningli@vip.163.com+86 13511026669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026